Scholars Central

CommentaryPublished 23 Dec 2024

Bioprinting and Drug Design: Transforming Pharmaceutical Development

Authors: Tom Laurens

Drug Designing: Open Access

Volume 13 · Issue 4 · Pages 1–2

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Bioprinting, a subset of 3D printing, has emerged as a revolutionary technology in various fields, including biotechnology, medicine and pharmaceutical development. The ability to fabricate three-dimensional biological structures using living cells, biomaterials and growth factors has the potential to transform drug discovery and design.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Drug Designing: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalDrug Designing: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Tom Laurens”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels